The Missing Mushroom: Psychedelic Science and the Future of Psilocybin

Psychedelic Science Review

November 3, 2021

read more News

Filament Health Announces Authorization Of Phase 2 Clinical Trial Studying Botanical Psilocybin For Prolonged Grief Disorder

Filament Health Announces Transition From OTCQB To OTC Pink Limited

Filament Health Announces Voluntary Delisting From Cboe Canada